QuarterHawk — Equity ResearchQuarterHawk — Equity Research

BrainsWay Ltd. (BWAY)

Healthcare

No action
Fundamental
3
Sentiment
3
Technical
2

Do Nothing: no run-date source in a partial run (runDate absent; inherited currentDate 2026-08-20 untrusted); cannot anchor chart or event windows.

Analysis as of 2026-09-10· more than 2 trading days ago

Company overview

BrainsWay Ltd. develops non-invasive neurostimulation therapies for mental health and neurological conditions. Its primary product, the Deep Transcranial Magnetic Stimulation (dTMS) platform, treats disorders such as depression, OCD, and PTSD. The company operates globally, serving medical professionals and centers specializing in psychiatry.

Fundamental

fair
Fundamental3
Strong growth, high valuation

BrainsWay shows strong revenue growth and profitability improvement, but trades at high valuation multiples.

BrainsWay shows strong revenue growth and a clear profitability inflection with a net-cash balance sheet, but it trades at demanding multiples (implied P/E ~78, EV/Sales ~10) while SEC risk factors highlight reimbursement, regulatory, and adoption sensitivity. Solid momentum, but valuation leaves limited room for execution missteps.

Sentiment

fair
Sentiment3
Mixed sentiment

Post-earnings sentiment is constructive but lacks immediate catalysts, with valuation concerns persisting.

Company-announced Q2’26 results and a raised full-year outlook (announced) are the dominant near-term driver and have been framed constructively in recent coverage. The 30–90d sentiment delta is indeterminate due to a baseline-news timeout, but the legal/regulatory screen surfaced no confirmed investigation or litigation overhang and Reddit chatter appears minimal.

Technical

weak
Technical2
Data limitations

Technical analysis was not feasible due to data limitations, capping the technical score.

Fail-closed partial run: no runDate in the stage envelope and the inherited currentDate (2026-08-20) comes from a cached upstream stage, so no trustworthy anchor exists for chart, indicator, event, or staleness windows. Per the run-date rule and the stale-feed gate, the technical read is invalid as a claim about the current market: all 18 indicators are reported as 0 under the indicator-failure convention, technicalScore is capped at 2, setupType is no_setup, and the action is Do Nothing.

You’re looking at 2026-09-10 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.